Clinical trials
Completed Myelodysplastic Syndromes trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
964 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 32 |
| 2001 | 27 |
| 2002 | 36 |
| 2003 | 36 |
| 2004 | 29 |
| 2005 | 54 |
| 2006 | 41 |
| 2007 | 60 |
| 2008 | 56 |
| 2009 | 49 |
| 2010 | 49 |
| 2011 | 39 |
| 2012 | 43 |
| 2013 | 57 |
| 2014 | 44 |
| 2015 | 38 |
| 2016 | 38 |
| 2017 | 31 |
| 2018 | 32 |
| 2019 | 18 |
| 2020 | 21 |
| 2021 | 20 |
| 2022 | 10 |
| 2023 | 5 |
| 2024 | 5 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 964 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 82 |
| Memorial Sloan Kettering Cancer Center | 42 |
| Celgene | 37 |
| Fred Hutchinson Cancer Center | 35 |
| National Heart, Lung, and Blood Institute (NHLBI) | 26 |
| National Cancer Institute (NCI) | 22 |
| Novartis Pharmaceuticals | 21 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 20 |
| Case Comprehensive Cancer Center | 18 |
| Masonic Cancer Center, University of Minnesota | 18 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 964 |
| Leukemia, Myeloid, Acute | 531 |
| Leukemia | 372 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 286 |
| Leukemia, Myelomonocytic, Chronic | 210 |
| Lymphoma, Non-Hodgkin | 207 |
| Myeloproliferative Disorders | 198 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 189 |
| Hodgkin Disease | 186 |
| Multiple Myeloma | 184 |
Trials
Showing 26 to 50 of 964. Each trial links to its page on Pharma Observatory.
864 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.